(Q35024473)

5 August 2017

1 reference

title

Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy (English)

1 reference

5 August 2017

Paolo Anderlini

1

1 reference

PubMed ID

12479596

5 August 2017

Richard Champlin

series ordinal

2

1 reference

5 August 2017

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

62 Suppl 1

1 reference

5 August 2017

79-88

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262001-00006

5 August 2017

0 references

cites work

Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line

1 reference

12 December 2020

A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients

1 reference

12 December 2020

The utilization of cytokines in stem cell mobilization strategies

1 reference

12 December 2020

Peripheral blood stem cell autografts for the treatment of childhood cancer: a review of the Japanese experience. Japanese Cooperative Study Group of PBSCT (JCSG/PBSCT).

1 reference

12 December 2020

Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis

1 reference

12 December 2020

Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.

1 reference

12 December 2020

Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients.

1 reference

12 December 2020

Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor

1 reference

12 December 2020

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

1 reference

12 December 2020

Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies

1 reference

12 December 2020

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

12 December 2020

Peripheral blood progenitor cell mobilization: a clinical review.

1 reference

12 December 2020

Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane

1 reference

12 December 2020

Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery followin

1 reference

12 December 2020

Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)

1 reference

12 December 2020

Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys

1 reference

12 December 2020

Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia

1 reference

12 December 2020

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

1 reference

12 December 2020

Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection

1 reference

12 December 2020

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients

1 reference

12 December 2020

A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation

1 reference

12 December 2020

Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.

1 reference

12 December 2020

Filgrastim (r-metHuG-CSF): the first 10 years.

1 reference

12 December 2020

Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both

1 reference

12 December 2020

The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer

1 reference

12 December 2020

Autologous peripheral blood progenitor-cell transplantation versus autologous bone marrow transplantation for adults and children with non-leukaemic malignant disease. A randomised economic study

1 reference

12 December 2020

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

12 December 2020

Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia

1 reference

12 December 2020

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

12 December 2020

Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?

1 reference

12 December 2020

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer

1 reference

12 December 2020

G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs

1 reference

12 December 2020

Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations.

1 reference

12 December 2020

Allogeneic blood stem cell transplantation: considerations for donors.

1 reference

12 December 2020

The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis

1 reference

12 December 2020

Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy

1 reference

12 December 2020

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques

1 reference

12 December 2020

The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective study

1 reference

12 December 2020

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer

1 reference

12 December 2020

Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood

1 reference

12 December 2020

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

1 reference

12 December 2020

Prospective Randomized Study Comparing the Efficacy of Bioequivalent Doses of glycosylated and nonglycosylated rG-CSF for Mobilizing Peripheral Blood Progenitor Cells

1 reference

12 December 2020

Hyperleukocytosis and retinal hemorrhages after chemotherapy and Filgrastim administration for peripheral blood progenitor cell mobilization.

1 reference

12 December 2020

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

1 reference

12 December 2020

Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

1 reference

12 December 2020

Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease

1 reference

12 December 2020

Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy

1 reference

12 December 2020

Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.

1 reference

12 December 2020

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

12 December 2020

Economic analysis of a phase III study of G-CSF vs placebo following allogeneic blood stem cell transplantation

1 reference

12 December 2020

Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial

1 reference

12 December 2020

Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial

1 reference

12 December 2020

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

1 reference

12 December 2020

Regulation of hematopoiesis by microvascular endothelium

1 reference

12 December 2020

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

1 reference

12 December 2020

A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

1 reference

12 December 2020

Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion.

1 reference

12 December 2020

Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.

1 reference

12 December 2020

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

12 December 2020

Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost

1 reference

12 December 2020

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

12 December 2020

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

12 December 2020

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer

1 reference

12 December 2020

Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

1 reference

12 December 2020

Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation

1 reference

12 December 2020

Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease

1 reference

12 December 2020

10.2165/00003495-200262001-00006

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

12479596